Does CERC-501 Attenuate Stress-precipitated Smoking Lapse?
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2018
At a glance
- Drugs CERC 501 (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 12 Jan 2018 Status changed from active, no longer recruiting to completed.
- 11 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Nov 2017 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.